Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SPS COMMERCE INCSPSC · Entity 4230 | Director | May 28, 2026 | June 01, 2026 |
| Spectrum Brands Holdings, Inc.SPB · Entity 4515 | Director | December 22, 2020 | December 23, 2020 |
| Vanda Pharmaceuticals Inc.VNDA · Entity 5861 | Director | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SPS COMMERCE INC
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,870 |
Reported balance
After 2026-05-28 transaction · row 1
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 3,736 · Balance 7,870 F1: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2026, provided the recipient remains a member of the board as of the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2026, provided the recipient remains a member of the board as of the vesting date.
Spectrum Brands Holdings, Inc.
Report date December 22, 2020 · Filed December 23, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,533 |
Reported balance
After 2020-12-22 transaction · row 1
1 source rowRow 1 · 2020-12-22 · Grant · Acquired 3,533 · Balance 3,533 F1: Reporting Person was awarded restricted stock units under the Company's 2011 Omnibus Equity Award Plan which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2021 if Reporting Person is a director of the Issuer on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting Person was awarded restricted stock units under the Company's 2011 Omnibus Equity Award Plan which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2021 if Reporting Person is a director of the Issuer on such date.
Vanda Pharmaceuticals Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 160,667 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 41,600 · Balance 160,667 F1: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027 provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027 provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 20:19 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 41,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-261790 · ownership.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,667 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027 provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 20:46 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 3,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-039559 · wk-form4_1780346807.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,870 F1 · shares: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2026, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:34 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 59,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083884 · ownership.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,067 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:15 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026048 · wk-form4_1747343695.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,134 F1 · shares: This reflects a restricted stock unit award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2025, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:52 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 37,578 | $0.00 Strike: $5.48 | $0.00 |
DisclosureSEC source: 0000950170-24-063015 · ownership.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,578 Underlying: Common Stock · 37,578 shares Expires 2034-05-16 F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:52 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 20,529 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063015 · ownership.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,842 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 16, 2024 Filed May 21, 2024 00:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 1,136 | $0.00 Strike: $80.31 | $0.00 |
DisclosureSEC source: 0001437749-24-017738 · rdgdoc.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,136 Underlying: Common Stock · 1,136 shares Expires 2031-05-16 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2024, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 16, 2024 Filed May 21, 2024 00:06 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 465 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017738 · rdgdoc.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,824 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2024, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:20 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 33,960 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-23-036289 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,960 Underlying: Common Stock · 33,960 shares Expires 2033-06-07 F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:20 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 17,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-036289 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,313 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 12, 2023 Filed May 17, 2023 00:04 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 1,466 | $0.00 Strike: $155.72 | $0.00 |
DisclosureSEC source: 0001209191-23-029966 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,466 Underlying: Common Stock · 1,466 shares Expires 2030-05-12 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2023, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 12, 2023 Filed May 17, 2023 00:04 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 585 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029966 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,359 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2023, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:55 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 24,707 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0001209191-22-038449 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,707 Underlying: Common Stock · 24,707 shares Expires 2032-06-15 F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:55 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 12,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038449 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,006 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 17, 2022 Filed May 19, 2022 21:08 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 2,252 | $0.00 Strike: $104.31 | $0.00 |
DisclosureSEC source: 0001209191-22-030616 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,252 Underlying: Common Stock · 2,252 shares Expires 2029-05-17 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2022, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 17, 2022 Filed May 19, 2022 21:08 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030616 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,774 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2022, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:36 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.21 | $0.00 |
DisclosureSEC source: 0001209191-21-040243 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:36 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040243 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:35 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034933 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:35 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034933 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:03 UTC Amendment | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035832 · doc4a.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:03 UTC Amendment | SPS COMMERCE INC SPSC · Entity 4230 | GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035832 · doc4a.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:19 UTC | SPS COMMERCE INC SPSC · Entity 4230 | GrantStock Option (right to buy) · Derivative | 5,233 | $0.00 Strike: $110.42 | $0.00 |
DisclosureSEC source: 0001209191-21-013313 · doc4.xml · derivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,233 Underlying: Common Stock · 5,233 shares Expires 2028-02-19 F1 · derivative.exercise_date: Options vest in 36 equal monthly installments over three years commencing on the first day of the calendar month following the initial appointment to the board. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:43 UTC | Spectrum Brands Holdings, Inc. SPB · Entity 4515 | GrantCommon Stock | 3,533 | $0.00 | $0.00 |
DisclosureSEC source: 0000109177-20-000066 · wf-form4_160875979516416.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 F1 · shares: Reporting Person was awarded restricted stock units under the Company's 2011 Omnibus Equity Award Plan which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2021 if Reporting Person is a director of the Issuer on such date. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 23:12 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.57 | $0.00 |
DisclosureSEC source: 0001209191-20-036785 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-10 F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 23:12 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036785 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
| October 28, 2019 Filed Oct 29, 2019 01:47 UTC | Vanda Pharmaceuticals Inc. VNDA · Entity 5861 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $14.21 | $0.00 |
DisclosureSEC source: 0001209191-19-054300 · doc4.xml · derivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-10-27 F1 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares when the Reporting Person completes 12 months of continuous service following the date of grant, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.